ChoA Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
ChoA Pharmaceutical has a total shareholder equity of ₩38.8B and total debt of ₩15.7B, which brings its debt-to-equity ratio to 40.4%. Its total assets and total liabilities are ₩74.2B and ₩35.5B respectively.
Key information
40.4%
Debt to equity ratio
₩15.66b
Debt
Interest coverage ratio | n/a |
Cash | ₩4.36b |
Equity | ₩38.76b |
Total liabilities | ₩35.46b |
Total assets | ₩74.22b |
Financial Position Analysis
Short Term Liabilities: A034940's short term assets (₩42.2B) exceed its short term liabilities (₩29.2B).
Long Term Liabilities: A034940's short term assets (₩42.2B) exceed its long term liabilities (₩6.3B).
Debt to Equity History and Analysis
Debt Level: A034940's net debt to equity ratio (29.1%) is considered satisfactory.
Reducing Debt: A034940's debt to equity ratio has increased from 31% to 40.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A034940 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A034940 has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 42.8% each year.